TipRanks
Go Ultimate55% OFF

ETFs with Guangdong True Health Medical Technology Development Co. Ltd. Class H (2697) Exposure

The following ETFs maintain exposure to Guangdong True Health Medical Technology Development Co. Ltd. Class H (HK:2697). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.

2 ETFs Hold Guangdong True Health Medical Technology Development Co. Ltd. Class H (2697)

ETFs holding HK:2697
SymbolETF NameAUMExpense Ratio% Weight in ETFMarket Value% Weight in 2697
CYBOVanEck Bionic Engineering UCITS ETF Accum -A- USD$14.58M0.55%0.06%$8,642.7<0.01%
GINNGoldman Sachs ETF Trust Goldman Sachs Innovate Equity ETF$178.46M0.50%<0.01%$8,701.89<0.01%
Find ETFs with the TipRanks ETF screener

Popular ETFs

Popular ETFs
CompanyPrice & ChangeFollow
SPYSPDR S&P 500 ETF Trust―
QQQInvesco QQQ Trust―
DIASPDR Dow Jones Industrial Average ETF Trust―
IWMiShares Russell 2000 ETF―
VOOVanguard S&P 500 ETF―

2697 ETF Exposure FAQ

What ETFs hold Guangdong True Health Medical Technology Development Co. Ltd. Class H stock?
Guangdong True Health Medical Technology Development Co. Ltd. Class H (HK:2697) is currently held by 2 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to HK:2697 include Goldman Sachs (GINN) and VanEck (GB:CYBO).
Which ETF has the largest exposure to HK:2697?
The ETF with the largest exposure to HK:2697 is Goldman Sachs (GINN), with approximately $8,701.89 in market value exposure.
How much HK:2697 stock is held by ETFs?
ETFs currently hold approximately $17.34K worth of Guangdong True Health Medical Technology Development Co. Ltd. Class H (HK:2697) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.